Apollo Therapeutics raises $226.5m to develop medicines based on uni research
Company founded by the tech transfer offices of Imperial, Cambridge and UCL has raised major Series C funding to turn basic research into medicines.
Imperial announces improved Founders Choice programme for spinout companies
Imperial has made important improvements to Founders Choice, its spinout formation and support approach.
New centre to develop sustainable materials for a green future
New $150 million research centre at Imperial College London will develop sustainable routes to materials for a green future.
Video
New quantum technologies to be developed in Imperial initiative
Imperial has launched an initiative to gather its world-leading experts in quantum science and engineering to develop technologies of the future.
Quantum sensor for a future navigation system tested aboard Royal Navy ship
A prototype quantum sensor built at Imperial, with potential application in GPS-free navigation, has been tested in collaboration with the Royal Navy.
1
Imperial and Agilent renew partnership for flagship analytical science facility
Imperial and Agilent Technologies have announced the extension of their partnership to support advanced analytical science.
MSD partners with Imperial to access insights for better health
Pharmaceutical company MSD has partnered with Imperial to reveal insights that will aid its mission to support clinicians and save and improve lives.
Imperial partnering with EnteroBiotix to advance microbiome medical treatments
Imperial is partnering with biotechnology company EnteroBiotix on research into the potential of therapies based on the gut bacterial community.
New startup to help pharmaceutical companies develop nanoparticle medicines
Imperial startup SPARTA Biodiscovery is offering technology to accelerate the development and production of nanoparticles used in advanced medicines.
2
National hub to support synthetic biology extended with £5.5m funding commitment
SynbiCITE, the UK’s National Centre for the Industrial Translation of Synthetic Biology, has received a £5.5m funding commitment from SynBioVen.
1
